Table 5.
Multivariate Analysis of Prognostic Value of AML Patients
CR | RFS | OS | ||||
---|---|---|---|---|---|---|
p | OR (95%C.I) | p | HR (95%C.I) | p | HR (95%C.I) | |
CR vs NCR | 0.528 | 1.264 (0.611 – 2.617) | 0.993 | 1.003 (0.454 – 2.218) | ||
FLT3/ITD | 0.032* | 2.872 (1.098–7.513) | 0.856 | 1.059 (0.571 – 1.964) | 0.192 | 1.593 (0.791 –3.207) |
lnRNA ANRIL | 0.011* | 3.449 (1.324–8.985) | 0.001* | 3.504 (1.662 – 7.387) | 0.005* | 3.353 (1.434– 7.839) |
lnRNA SNHG14 | 0.005* | 3.955 (1.510–10.356) | 0.001* | 4.094 (1.849 – 9.067) | 0.012* | 3.094 (1.277 –7.494) |
HR, Hazard ratio; OR,: Odd`s ratio; C.I, Confidence interval; LL, Lower limit; UL, Upper Limit; #, All variables with p<0.05 was included in the multivariate; *, Statistically significant at p ≤ 0.05